Filing Details
- Accession Number:
- 0001250853-18-000153
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-11 21:15:52
- Reporting Period:
- 2018-12-07
- Accepted Time:
- 2018-12-11 21:15:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1335105 | Lixte Biotechnology Holdings Inc. | LIXT.OB | Pharmaceutical Preparations (2834) | 202903526 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1472409 | Gil Schwartzberg | 5500 Military Trail, Suite 22 Jupiter FL 33458 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-12-07 | 1,040,000 | $0.50 | 1,895,068 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-12-07 | 150,000 | $0.00 | 2,045,068 | No | 4 | J | Direct | |
| Common Stock | Disposition | 2018-12-07 | 600,000 | $0.00 | 1,066,356 | No | 4 | G | Indirect | By Gil & Debbie Schwartzberg Family Trust, Gil Schwartzberg Separate Property |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | J | Direct | |
| No | 4 | G | Indirect | By Gil & Debbie Schwartzberg Family Trust, Gil Schwartzberg Separate Property |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrants to Purchase Common Stock | Acquisiton | 2018-12-07 | 1,040,000 | $0.50 | 1,040,000 | $1.00 |
| Common Stock | Warrants to Purchase Common Stock | Disposition | 2018-12-07 | 1,040,000 | $0.00 | 1,040,000 | $1.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,540,000 | 2018-12-07 | 2022-11-30 | No | 4 | P | Direct |
| 0 | 2018-12-07 | 2022-11-30 | No | 4 | G | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 63,811 | Indirect | By Continuum Partners, L.P. |
Footnotes
- The reporting person acquired 1,040,000 Units, each Unit consisting of one share of Common Stock and a four year warrant at an exercise price of $1.00 per share. The purchase price for a Unit was $0.50.
- Represents shares acquired by the reporting person pursuant to enforcement of a judgment.
- Represents the reporting person's proportionate interest in Continuum Partners, L.P. which owns 638,115 shares of the issuer's common stock.
Billionaire Hedge Funds
